MedTrace Logo

Yellow Fever Human Infection Model With YF-17D

NCT05901454 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-06-13

No results posted yet for this study

Summary

No antiviral treatment exists for yellow fever, only supportive care, and therefore we rely on prevention through vaccination. Although this vaccine is very effective, stockpiles are insufficient in outbreak situations and some people have a contraindication to be vaccinated. For those who are unprotected and at risk of yellow fever infection, treatment could be life saving.

Conditions

  • Yellow Fever

Interventions

DRUG

Yellow Fever Vaccine

vaccination according to manufacturers manual (0.5mL subcutaneously in the arm)

Sponsors & Collaborators

  • The International Society of Travel Medicine

    collaborator UNKNOWN

  • Leiden University Medical Center

    lead OTHER

Principal Investigators

  • Anna HE Roukens, MD PhD · Leiden University Medical Center

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-17
Primary Completion
2023-07-01
Completion
2024-03-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05901454 on ClinicalTrials.gov